Partial interferon-gamma receptor 1 deficiency in a child with tuberculoid bacillus Calmette-Guérin infection and a sibling with clinical tuberculosis.
about
Expression of inducible nitric oxide synthase in human granulomas and histiocytic reactionsMutation in the signal-transducing chain of the interferon-gamma receptor and susceptibility to mycobacterial infectionAdjuvant interferon gamma in patients with drug - resistant pulmonary tuberculosis: a pilot studyMendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-γ immunityBacillus Calmette-Guérin (BCG) complications associated with primary immunodeficiency diseasesStriking the Right Balance Determines TB or Not TBNew Insights into IDO Biology in Bacterial and Viral Infections.Persistent high mortality in advanced HIV/TB despite appropriate antiretroviral and antitubercular therapy: an emerging challengeAcylation determines the toll-like receptor (TLR)-dependent positive versus TLR2-, mannose receptor-, and SIGNR1-independent negative regulation of pro-inflammatory cytokines by mycobacterial lipomannanMycobacterium tuberculosis catalase and peroxidase activities and resistance to oxidative killing in human monocytes in vitroCompartmentalized bronchoalveolar IFN-gamma and IL-12 response in human pulmonary tuberculosisIncreased production of IL-4 and IL-12p40 from bronchoalveolar lavage cells are biomarkers of Mycobacterium tuberculosis in the sputumSuppression of the NF-κB pathway by diesel exhaust particles impairs human antimycobacterial immunityHIV and Tuberculosis: a Deadly Human SyndemicGenetic susceptibility to tuberculosis.A novel form of cell type-specific partial IFN-gammaR1 deficiency caused by a germ line mutation of the IFNGR1 initiation codon.Acquired predisposition to mycobacterial disease due to autoantibodies to IFN-gamma.Novel STAT1 alleles in otherwise healthy patients with mycobacterial disease.Natural variation in immune responses to neonatal Mycobacterium bovis Bacillus Calmette-Guerin (BCG) Vaccination in a Cohort of Gambian infants.Polymorphic variation in TIRAP is not associated with susceptibility to childhood TB but may determine susceptibility to TBM in some ethnic groupsInnate defects of the IL-12/IFN-γ axis in susceptibility to infections by mycobacteria and salmonellaInterferon-gamma-responsive nonhematopoietic cells regulate the immune response to Mycobacterium tuberculosisHuman genetics of tuberculosis: a long and winding road.Inheritable defects in interleukin-12- and interferon-gamma-mediated immunity and the TH1/TH2 paradigm in man.CD36 deficiency attenuates experimental mycobacterial infection.Biologic functions of the IFN-gamma receptors.Resistance of virulent Mycobacterium avium to gamma interferon-mediated antimicrobial activity suggests additional signals for induction of mycobacteriostasis.Mice with a selective impairment of IFN-gamma signaling in macrophage lineage cells demonstrate the critical role of IFN-gamma-activated macrophages for the control of protozoan parasitic infections in vivoCorrelates of protective immunity to Mycobacterium tuberculosis in humans.A point mutation in a domain of gamma interferon receptor 1 provokes severe immunodeficiency.Gamma interferon-producing CD4+ T lymphocytes in the lung correlate with resistance to infection with Mycobacterium tuberculosis.Clinical consequences of defects in the IL-12-dependent interferon-gamma (IFN-gamma) pathway.Mycobacterial PIMs inhibit host inflammatory responses through CD14-dependent and CD14-independent mechanismsTracking antigen-specific CD8 T lymphocytes in the lungs of mice vaccinated with the Mtb72F polyprotein.Identification of probable early-onset biomarkers for tuberculosis disease progression.Genetic predisposition to clinical tuberculosis: bridging the gap between simple and complex inheritance.Gamma interferon is dispensable for neopterin production in vivoM. tuberculosis induces potent activation of IDO-1, but this is not essential for the immunological control of infection.Impaired interferon gamma-mediated immunity and susceptibility to mycobacterial infection in childhood.Cytokines and immunodeficiency diseases.
P2860
Q22008706-668205AD-3BDB-4CE8-94AA-635EFEAA6208Q24322505-D56A3B4F-CAD3-449B-B895-1E6638E2D518Q24795200-9D0DC5B5-AB0E-4954-BA02-685F0AED15C0Q26862947-4A4C5250-0AD8-40A7-B09D-9A4C8AF1BC01Q26863260-F366B63C-B0AF-4D26-BD8D-67FB889DF4A5Q27001010-F3FF928B-2233-46D4-A0B6-CE6FCFAD3710Q27692028-A5905B9B-B11A-4947-9BEB-E699A830B17FQ28088557-C100F121-0588-4391-B190-54E7CE19C319Q28235685-81808B74-CB84-4149-ADCF-4DAE425F20DFQ28369434-42E58656-8BC2-46E6-9360-DC66E130B788Q28387743-44FFFE97-55C9-4A57-B547-265043EEB073Q28395969-47977541-5905-4EA8-978C-7D0F5CF32BFFQ28397253-02DF6442-1E13-43E5-8C05-DF54B2096FE9Q30052157-18ABAF9D-B9B7-4523-A754-CF769DD685C2Q30332232-65BEF3FB-8EC4-4D92-B164-62BEE1732AABQ30492620-5587CB26-E098-46BE-A2F0-D469CFF22AC2Q33222437-44E747F1-A502-49E6-93DE-1077A9B105B3Q33255341-AFAAA364-8390-4112-A712-4A468F611E92Q33378483-D0786A25-71D7-4721-A53D-27DD78AC8600Q33495167-2D5453D9-4715-4968-BA27-E0EE8D01C13CQ33588166-6930830B-C5D0-4142-AE82-D6A54F686430Q33596687-DC4A47CA-7FC8-4E74-AC24-617ABD64444EQ33624576-9F0BC377-5045-4572-B6D7-F0C61A1D5764Q33669243-67169474-E2A3-44D5-9192-F3B25D3FEA9DQ33719919-AA14FC6B-CE1F-4D81-8BC5-CF4A8D6EA419Q33846008-CB5D82E1-5AAE-4686-8B95-05EFB7A1423DQ33877236-23FBD82A-9061-4D40-A4D6-5E88BD4050F9Q33915925-A454E5F9-72E4-4536-AA8D-2AFD75D0C20AQ33956267-AAFAC1D2-C152-497E-855D-CD8CC4BB211EQ33998861-F6654A1A-507B-4512-833A-73018E04508EQ34007030-D929D832-9EA3-4CED-8849-B2FB91B2E999Q34022537-72D3B30A-C3EF-43A4-8165-20F9B6450E3AQ34031415-3D2C6C98-2612-4B68-A5EC-8BECF73A4400Q34034191-686C2E8F-A3D4-47F6-9B88-0D658745B8DFQ34038097-320895E3-3DE6-4429-9B7D-96D39BD0449AQ34142035-B5FAA300-A3A6-4517-A76C-FDA6EE02CA2BQ34231224-AC0D225B-346E-462D-BE5F-D40015E9FBE6Q34287451-CB3F04A8-4F4E-4DA1-A127-4BC2B8F0C0B6Q34290095-F184CD04-7769-4929-9128-3ABC0DD55973Q34572193-DB4C5AAC-2D0D-43D5-9450-9577545054BF
P2860
Partial interferon-gamma receptor 1 deficiency in a child with tuberculoid bacillus Calmette-Guérin infection and a sibling with clinical tuberculosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 1997
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Partial interferon-gamma recep ...... ng with clinical tuberculosis.
@en
Partial interferon-gamma recep ...... ng with clinical tuberculosis.
@nl
type
label
Partial interferon-gamma recep ...... ng with clinical tuberculosis.
@en
Partial interferon-gamma recep ...... ng with clinical tuberculosis.
@nl
prefLabel
Partial interferon-gamma recep ...... ng with clinical tuberculosis.
@en
Partial interferon-gamma recep ...... ng with clinical tuberculosis.
@nl
P2093
P2860
P356
P1476
Partial interferon-gamma recep ...... ng with clinical tuberculosis.
@en
P2093
Casanova JL
Fondanèche MC
Gaillard JL
Lamhamedi-Cherradi S
P2860
P304
P356
10.1172/JCI119810
P407
P577
1997-12-01T00:00:00Z